This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

56/100

✓ Peer-reviewed alzhub usefulness score 56 out of 100. Prevention and risk

Topic: Risk, prevention and care in population studies

Type 2 diabetes and cognitive dysfunction are highly prevalent disorders worldwide. Although type 2 diabetes is associated with an increased risk of dementia, awareness of the link between the two conditions is poor, and few recommendations are available to guide clinicians about how to approach cognitive dysfunction in people with diabetes. Clinical guidelines in diabetes have only recently begun to emphasise the importance of cognitive impairment in diabetes and its management. This Series paper aims to synthesise knowledge about the link between diabetes and cognitive dysfunction, issues pertaining to screening and diagnosis of cognitive impairment and dementia in those with type 2 diabetes, management of diabetes in people with cognitive dysfunction (accounting for age and frailty), and emerging therapies for prevention. A conceptual framework for approaching screening and diagnosis is included, and future research directions to guide the field forward are suggested.

Key findings

Although type 2 diabetes is associated with an increased risk of dementia, awareness of the link between the two conditions is poor, and few recommendations are available to guide clinicians about how to approach cognitive dysfunction in people with diabetes.

Why it matters

This paper states that type 2 diabetes is associated with an increased risk of dementia but that awareness of this link among clinicians is poor and few guidelines exist. It calls for better screening and management rather than reporting a proven way to prevent or treat dementia.

New to this subject? Start with our plain-English guide: Prevention →

Study details

Evidence strengthLow

How this study scored 56/100

Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomised / blinded because the record does not state it.

Component	Points	Why
Journal tier	7 / 10	Tier 3 — peer-reviewed journal (The lancet. Diabetes & endocrinology)
Journal's citation record	3 / 4	The Lancet Diabetes & Endocrinology: journal h-index 250 (OpenAlex, 2026-10-29)
Study design	0 / 12	No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence	1 / 5	Rated “low” in our summary
Peer-review validation	10 / 10	Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent	2 / 5	2020 — within 10 year(s) of the newest study here
Sample size	0 / 4	Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported	0 / 3	No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people	0 / 3	Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomised / blinded	0 / 2	No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited	6 / 7	Cited 460 times (OpenAlex, 2026-10-10)
Citations per year	5 / 5	57.5 citations a year over 8 year(s) since 2020
Impact for its field and year	5 / 6	Cited 29.8× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here	3 / 6	Cited by 12 other studies in this library
Still being cited	4 / 4	Cited 273 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record	4 / 4	Last-listed author Geert Jan Biessels: h-index 105 (OpenAlex, whole career)
Institution's track record	2 / 3	Johns Hopkins University: institution h-index 2,306 (OpenAlex)
Multi-centre collaboration	2 / 3	OpenAlex lists 6 institution(s) in 4 countries
Indexed in PubMed	2 / 2	Indexed in PubMed (PMID 32445740)
Free to read	0 / 2	Behind a paywall — scores zero
Total	56 / 100	—

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

APA 7th

Srikanth, V., Sinclair, A. J., Hill-Briggs, F., Moran, C., & Biessels, G. J. (2020). Type 2 diabetes and cognitive dysfunction-towards effective management of both comorbidities. The lancet. Diabetes & endocrinology. https://doi.org/10.1016/s2213-8587(20)30118-2

Vancouver

Srikanth V, Sinclair AJ, Hill-Briggs F, Moran C, Biessels GJ. Type 2 diabetes and cognitive dysfunction-towards effective management of both comorbidities. The lancet. Diabetes & endocrinology. 2020. doi:10.1016/s2213-8587(20)30118-2. PMID: 32445740.

BibTeX

@article{srikanth2020-32445740,
  author  = {Srikanth, V. and Sinclair, A. J. and Hill-Briggs, F. and Moran, C. and Biessels, G. J.},
  title   = {{Type 2 diabetes and cognitive dysfunction-towards effective management of both comorbidities}},
  journal = {The lancet. Diabetes \& endocrinology},
  year    = {2020},
  doi     = {10.1016/s2213-8587(20)30118-2},
  pmid    = {32445740},
  url     = {https://doi.org/10.1016/s2213-8587(20)30118-2}
}

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 29.

Later studies that cite this one

12 studies in the alzhub library list this one in their references. Showing the 8 highest-scoring.

Related studies in Prevention and risk

Also tagged “assessment”

840 studies in the library carry the topic tag “assessment”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 840 tagged studies.

Similar studies

More on Prevention and risk

See all studies in Prevention and risk →